425 related articles for article (PubMed ID: 36836185)
21. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
22. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
[TBL] [Abstract][Full Text] [Related]
23. The Gut-Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics.
Saxami G; Kerezoudi EN; Eliopoulos C; Arapoglou D; Kyriacou A
Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895405
[TBL] [Abstract][Full Text] [Related]
24. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
25. Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects.
Bhalla D; Dinesh S; Sharma S; Sathisha GJ
Neurochem Res; 2024 Apr; 49(4):847-871. PubMed ID: 38244132
[TBL] [Abstract][Full Text] [Related]
26. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology.
Saulnier DM; Ringel Y; Heyman MB; Foster JA; Bercik P; Shulman RJ; Versalovic J; Verdu EF; Dinan TG; Hecht G; Guarner F
Gut Microbes; 2013; 4(1):17-27. PubMed ID: 23202796
[TBL] [Abstract][Full Text] [Related]
27. Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.
Aljeradat B; Kumar D; Abdulmuizz S; Kundu M; Almealawy YF; Batarseh DR; Atallah O; Ennabe M; Alsarafandi M; Alan A; Weinand M
Pathophysiology; 2024 May; 31(2):244-268. PubMed ID: 38804299
[TBL] [Abstract][Full Text] [Related]
28. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease.
Yang D; Zhao D; Ali Shah SZ; Wu W; Lai M; Zhang X; Li J; Guan Z; Zhao H; Li W; Gao H; Zhou X; Yang L
Front Neurol; 2019; 10():1155. PubMed ID: 31781020
[TBL] [Abstract][Full Text] [Related]
29. The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications.
Khawar MM; Ijaz S; Goyal P; Kandambige D; Sharifa M; Maslamani ANJ; Al Kutabi S; Saleh I; Albshir MM; I Kh Almadhoun MK; Soomro SN; Kumari N
Cureus; 2023 Nov; 15(11):e48655. PubMed ID: 38090441
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review.
Sonali S; Ray B; Ahmed Tousif H; Rathipriya AG; Sunanda T; Mahalakshmi AM; Rungratanawanich W; Essa MM; Qoronfleh MW; Chidambaram SB; Song BJ
Cells; 2022 Apr; 11(8):. PubMed ID: 35456041
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk Between the Gut Microbiota and the Brain: An Update on Neuroimaging Findings.
Liu P; Peng G; Zhang N; Wang B; Luo B
Front Neurol; 2019; 10():883. PubMed ID: 31456743
[TBL] [Abstract][Full Text] [Related]
32. Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders.
Geng ZH; Zhu Y; Li QL; Zhao C; Zhou PH
Front Aging Neurosci; 2022; 14():810483. PubMed ID: 35517052
[TBL] [Abstract][Full Text] [Related]
33. Epilepsy and the gut: Perpetrator or victim?
Al-Beltagi M; Saeed NK
World J Gastrointest Pathophysiol; 2022 Sep; 13(5):143-156. PubMed ID: 36187601
[TBL] [Abstract][Full Text] [Related]
34. Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance.
Tao W; Zhang Y; Wang B; Nie S; Fang L; Xiao J; Wu Y
J Adv Res; 2024 Apr; ():. PubMed ID: 38579985
[TBL] [Abstract][Full Text] [Related]
35. Role of the Gut-Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson's Disease.
Thangaleela S; Sivamaruthi BS; Kesika P; Bharathi M; Chaiyasut C
Microorganisms; 2022 Jul; 10(8):. PubMed ID: 36013962
[TBL] [Abstract][Full Text] [Related]
36. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
37. Remodeling of microbiota gut-brain axis using psychobiotics in depression.
Palepu MSK; Dandekar MP
Eur J Pharmacol; 2022 Sep; 931():175171. PubMed ID: 35926568
[TBL] [Abstract][Full Text] [Related]
38. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments.
Larroya-García A; Navas-Carrillo D; Orenes-Piñero E
Crit Rev Food Sci Nutr; 2019; 59(19):3102-3116. PubMed ID: 29870270
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options.
Kumar A; Pramanik J; Goyal N; Chauhan D; Sivamaruthi BS; Prajapati BG; Chaiyasut C
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111321
[TBL] [Abstract][Full Text] [Related]
40. The Molecular Gut-Brain Axis in Early Brain Development.
Muhammad F; Fan B; Wang R; Ren J; Jia S; Wang L; Chen Z; Liu XA
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
